Cancer Associated Thrombosis
Cancer is the highest single risk factor for thrombosis.
WHITE PAPER - SUMMARY
The impact of cancer-related comorbidities on patient treatment, treatment efficacy, survivorship, and quality of life
WHITE PAPER
The impact of cancer-related comorbidities on patient treatment, treatment efficacy, survivorship, and quality of life
COVID-19 and Thrombosis in Cancer Patients: The Clot Thickens
Prof Alok Khorana looks at hypercoagulability of COVID-19 and strategies and recommendations for anticoagulation.
Thrombosis UK joined with organizations representing patients, nurses and health experts to call on the European Commission to take into account cancer-related complications as it designs its European Beating Cancer Plan.
Patients and experts draw attention to cancer-related conditions.
All Party Parliamentary Group (APG) for Thrombosis March 2020
Report: VTE in Cancer Patients Cancer, Chemotherapy & Clots Survey 2016-1019
Patient Experience of Living With Cancer Associated Thrombosis in France (Le PELICAN)
Isabell Mahe, Jean Chidiac, Mickael Pinson, Parinita Swarnkar, Anne Marie Nelson, Simon Noble - May 2020
Warwick Clinical Trials Unit – selected Cancer associated thrombosis – a patient perspective
Cancer-associated thrombosis awareness survey - Results report - October 2018
European Cancer Patient Coalition
With support from LEO Pharma
Carried out by Quality Health Limited
Hospice inpatient deep vein thrombosis detection (HIDDen) in advanced non-malignant diseases’: a longitudinal pilot study - HIDDen Study, 2020
Clare White Simon Noble Flavia Swan Max Watson Victoria Allgar Eoin Napier Annmarie Nelson Miriam J Johnson